What does NERVGEN PHARMA CORP. do?

NERVGEN PHARMA CORP. is a public company in the Pharmaceutical Preparations industry, incorporated in A1. It is registered with the SEC under CIK 0001751912 and trades on NASDAQ under the ticker NGEN.

How many SEC filings has NERVGEN PHARMA CORP. made?

NERVGEN PHARMA CORP. has filed 20 documents with the SEC since 2018. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

NERVGEN PHARMA CORP.

NGEN NASDAQ CIK: 0001751912 Pharmaceutical Preparations Inc. in A1

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 20 filings →

Form	Description	Date
6-K	FORM 6-K	Mar 13, 2026
6-K	FORM 6-K	Feb 13, 2026
6-K	FORM 6-K	Feb 10, 2026
S-8	FORM S-8	Jan 23, 2026
6-K	FORM 6-K	Jan 8, 2026
EFFECT	—	Jan 7, 2026
CERT	—	Jan 7, 2026
8-A12B	8-A12B	Jan 7, 2026
F-10/A	F-10/A	Jan 7, 2026
F-X	FORM F-X	Dec 17, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for NERVGEN PHARMA CORP.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001751912
Ticker: NGEN
Exchange: NASDAQ
Incorporated: A1
First Filing: 2018
Total Filings: 20

Pharmaceutical Preparations rankings →